We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.29B
AUM Growth
+$73M
Cap. Flow
+$288M
Cap. Flow %
8.77%
Top 10 Hldgs %
33.54%
Holding
352
New
136
Increased
52
Reduced
76
Closed
78

Top Buys

Rank Stock Value
1
LIVN icon
LivaNova
LIVN
+$42.5M
2
MAPS
WM TECHNOLOGY INC A
MAPS
+$23.3M
3
SEER icon
Seer Inc
SEER
+$20.8M
4
GKOS icon
Glaukos
GKOS
+$17.9M
5
COO icon
Cooper Companies
COO
+$17.1M

Top Sells

Rank Stock Value
1
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
+$60.7M
2
NTLA icon
Intellia Therapeutics
NTLA
+$26.2M
3
ORGO icon
Organogenesis Holdings
ORGO
+$19.9M
4
LLY icon
Eli Lilly
LLY
+$15.1M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.25%
2 Consumer Staples 0.8%
3 Technology 0.71%
4 Industrials 0.71%
5 Materials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARQT icon
176
Arcutis Biotherapeutics
ARQT
$3.3B
$2.68M 0.08%
112,324
-1,737
-2% -$39.6K
MRTX
177
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.65M 0.08%
15,000
-24,522
-62% -$3.95M
SNTI icon
178
Senti Biosciences Holdings
SNTI
$11.7M
$2.54M 0.08%
25,570
+570
+2% +$56.2K
CANO
179
CALL
DELISTED
Cano Health, Inc.
CANO
$2.54M 0.08%
+2,000
New +$2.42M
BEAM icon
180
Beam Therapeutics
BEAM
$2.76B
$2.14M 0.07%
24,573
-427
-2% -$42.9K
FRONU
181
DELISTED
Frontier Acquisition Corp. Units
FRONU
$2.1M 0.06%
213,023
-3,685
-2% -$36.7K
MDVL
182
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$2.08M 0.06%
14,282
-12,966
-48% -$3.93M
INCY icon
183
PUT
Incyte
INCY
$24.5B
$2.06M 0.06%
+30,000
New +$2.28M
BLU
184
DELISTED
BELLUS Health Inc.
BLU
$2.06M 0.06%
+334,805
New +$1.27M
EDIT icon
185
PUT
Editas Medicine
EDIT
$436M
$2.05M 0.06%
+50,000
New +$2.74M
EDIT icon
186
CALL
Editas Medicine
EDIT
$436M
$2.01M 0.06%
+48,900
New +$2.68M
IRON icon
187
Disc Medicine
IRON
$3.09B
$2M 0.06%
+16,480
New +$2.25M
DALS
188
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
$1.97M 0.06%
+200,000
New +$1.98M
ITCI
189
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.95M 0.06%
+52,213
New +$1.82M
IMGN
190
DELISTED
Immunogen Inc
IMGN
$1.95M 0.06%
343,048
-346,001
-50% -$2M
AVDL
191
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
$1.88M 0.06%
192,000
-3,200
-2% -$25.2K
FOLD
192
CALL
DELISTED
Amicus Therapeutics
FOLD
$1.88M 0.06%
196,800
-370,500
-65% -$3.79M
IMCR icon
193
Immunocore
IMCR
$1.77B
$1.85M 0.06%
+50,000
New +$1.69M
CGEM icon
194
Cullinan Oncology
CGEM
$1.26B
$1.84M 0.06%
81,418
-159,380
-66% -$4.26M
NUVB icon
195
Nuvation Bio
NUVB
$2.25B
$1.77M 0.05%
+178,403
New +$1.62M
THRN
196
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$1.73M 0.05%
+200,000
New +$1.63M
DCPH
197
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.7M 0.05%
+50,000
New +$1.6M
SRRA
198
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.61M 0.05%
73,633
-1,334
-2% -$26.7K
UTHR icon
199
United Therapeutics
UTHR
$21.9B
$1.58M 0.05%
+8,587
New +$1.69M
PMGMU
200
DELISTED
Priveterra Acquisition Corp. Units
PMGMU
$1.58M 0.05%
159,468
-2,004
-1% -$19.9K
6 7
8
9 10

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2021 Portfolio in Review

As of Q3 2021, Pura Vida Investments held 352 positions worth $3.29B, up 2.3% from $3.21B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Pura Vida Investments deployed $288M of net new capital in Q3 2021, opening 136 new positions and adding to 52 existing holdings. Its largest new stake was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was Intellia Therapeutics, an estimated $26.2M trimmed.

  • Pura Vida Investments's largest Q3 2021 buy was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.
  • Pura Vida Investments added most to LivaNova in Q3 2021, an estimated $42.5M increase.
  • Pura Vida Investments's biggest Q3 2021 reduction was Intellia Therapeutics, cutting an estimated $26.2M.
  • Pura Vida Investments fully exited Inovalon Holdings, Inc. Class A Common Stock in Q3 2021, selling an estimated $60.7M.
  • Pura Vida Investments's ten largest holdings make up 34% of its $3.29B portfolio in Q3 2021.
  • Pura Vida Investments opened 136 new positions and closed 78 in Q3 2021.
  • Pura Vida Investments's portfolio value rose 2.3% quarter-over-quarter to $3.29B.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.